Ajay K. Nooka, MBBS, on Maintenance Therapy: Benefits Reported in High-Risk Myeloma

Posted: Thursday, September 21, 2023

Ajay K. Nooka, MBBS, of Winship Cancer Center of Emory University, discusses phase II findings showing benefits for patients with high-risk myeloma who were given carfilzomib, pomalidomide, and dexamethasone as maintenance therapy. Dr. Nooka reviews the clinical considerations of this regimen.

---